GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sakar Healthcare Ltd (NSE:SAKAR) » Definitions » EV-to-FCF

Sakar Healthcare (NSE:SAKAR) EV-to-FCF : (As of Jan. 06, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Sakar Healthcare EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sakar Healthcare's Enterprise Value is ₹7,329 Mil. Sakar Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil. Therefore, Sakar Healthcare's EV-to-FCF for today is .

The historical rank and industry rank for Sakar Healthcare's EV-to-FCF or its related term are showing as below:

NSE:SAKAR' s EV-to-FCF Range Over the Past 10 Years
Min: -32.75   Med: 0   Max: 0
Current: -20.88

NSE:SAKAR's EV-to-FCF is not ranked
in the Drug Manufacturers industry.
Industry Median: 25.25 vs NSE:SAKAR: -20.88

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-01-06), Sakar Healthcare's stock price is ₹376.95. Sakar Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹5.665. Therefore, Sakar Healthcare's PE Ratio (TTM) for today is 66.54.


Sakar Healthcare EV-to-FCF Historical Data

The historical data trend for Sakar Healthcare's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sakar Healthcare EV-to-FCF Chart

Sakar Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only 16.47 -6.79 -29.07 -9.93 -25.61

Sakar Healthcare Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -25.61 - -

Competitive Comparison of Sakar Healthcare's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Sakar Healthcare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sakar Healthcare's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sakar Healthcare's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sakar Healthcare's EV-to-FCF falls into.



Sakar Healthcare EV-to-FCF Calculation

Sakar Healthcare's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=7328.696/0
=

Sakar Healthcare's current Enterprise Value is ₹7,329 Mil.
Sakar Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sakar Healthcare  (NSE:SAKAR) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Sakar Healthcare's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=376.95/5.665
=66.54

Sakar Healthcare's share price for today is ₹376.95.
Sakar Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5.665.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sakar Healthcare EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sakar Healthcare's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sakar Healthcare Business Description

Traded in Other Exchanges
N/A
Address
406, Silver Oaks Comm. Complex, Opposite Arun Society, Paldi, Ahmedabad, GJ, IND, 382 007
Sakar Healthcare Ltd is engaged in manufacturing Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections. The company offers its products to Sri Lanka, the Philippines, Vietnam, Cambodia, Sudan, Myanmar, Mauritius, Costa Rica, Panama, El Salvador and Paraguay.

Sakar Healthcare Headlines

No Headlines